The Centers for Disease Control and Prevention completed a study showing clear benefits of updated COVID-19 vaccines for adults — and a senior Trump administration official blocked its release. The suppression of taxpayer-funded research at the nation’s top public health agency marks one of the most concrete examples yet of political interference in scientific publishing under the current administration.
The study, conducted by CDC researchers, found that the updated 2024–2025 COVID-19 vaccines reduced the risk of hospitalization and emergency department visits among adults. It was peer-reviewed, accepted for publication, and ready for the public. Then it wasn’t.
According to reporting by Ars Technica, the study’s publication was halted after intervention by a political appointee within the Department of Health and Human Services. The official who blocked the release has not been publicly named, but multiple sources familiar with the matter confirmed the decision came from outside the CDC’s scientific leadership. The findings weren’t disputed on methodological grounds. They were simply inconvenient.
This isn’t a case of a study being sent back for further review or additional data analysis. The research had already cleared the standard scientific vetting process. It had been peer-reviewed by experts in the field. It had been accepted by a journal. The only thing standing between the data and the public was a political decision.
The implications are significant. COVID-19 continues to kill hundreds of Americans each week, and updated vaccines remain one of the most effective tools for reducing severe illness and death among older and immunocompromised populations. Suppressing evidence of vaccine efficacy doesn’t just undermine public trust in government science — it could directly influence whether people choose to get vaccinated.
And that, public health experts say, could cost lives.
The blocked study is part of a broader pattern. Since taking office, the Trump administration has moved aggressively to reshape federal health agencies. Thousands of CDC employees have been laid off or reassigned. Entire research programs have been defunded. The administration installed Robert F. Kennedy Jr., a longtime vaccine skeptic, as Secretary of Health and Human Services, a move that sent shockwaves through the scientific community. Kennedy has repeatedly questioned the safety and efficacy of vaccines — not just COVID-19 shots, but childhood immunizations as well.
Under Kennedy’s leadership, HHS has taken steps to limit the CDC’s traditional role in public health communication. Agency scientists have reportedly been told to avoid making public statements about vaccine benefits without prior approval from political staff. Internal communications reviewed by multiple news outlets suggest a chilling effect on researchers who fear professional retaliation for publishing findings that conflict with the administration’s skepticism toward vaccination.
The suppressed study used data from CDC’s longstanding surveillance networks, which track vaccine effectiveness in real time across hospitals and emergency departments nationwide. These networks — including VISION (Virtual SARS-CoV-2, Influenza, and Other respiratory viruses Network) — have been critical to understanding how well vaccines perform as the virus evolves. The 2024–2025 updated vaccines were reformulated to target the dominant circulating variants, and the blocked study reportedly showed they were doing their job: reducing the likelihood that vaccinated adults would end up in the hospital.
So why block it?
The administration hasn’t offered an official explanation. HHS did not respond to requests for comment from multiple outlets. But the timing and context tell their own story. The Trump White House has repeatedly signaled that it views the federal public health apparatus with suspicion. President Trump himself has made contradictory statements about vaccines, sometimes taking credit for Operation Warp Speed while simultaneously amplifying anti-vaccine voices within his political coalition.
Kennedy’s confirmation as HHS secretary turbocharged those tensions. Within weeks of taking office, Kennedy ordered a review of all CDC publications related to vaccines, a move that career scientists described as unprecedented. Previous administrations — both Republican and Democratic — have generally allowed CDC researchers to publish findings through established scientific channels without political pre-clearance. The new review process effectively gives political appointees veto power over what the public gets to see.
“This is not how science is supposed to work,” said one former CDC official who spoke on condition of anonymity. “You don’t suppress data because you don’t like the conclusion. That’s not a policy disagreement. That’s censorship.”
The episode also raises legal and ethical questions. Federal researchers who conduct studies with public funds operate under guidelines that are supposed to protect scientific integrity. Multiple executive orders and agency policies, some dating back decades, affirm that government scientists have the right to publish their findings and speak about their work. The Biden administration strengthened some of those protections in 2023 with a directive on scientific integrity across federal agencies. But executive orders can be rescinded, and the Trump administration has shown little inclination to honor its predecessor’s commitments on this front.
Congressional Democrats have already seized on the blocked study. Representatives from the House Energy and Commerce Committee’s minority caucus sent a letter to HHS demanding the study’s immediate release and a full accounting of which officials were involved in the decision. “The American people paid for this research,” the letter read. “They have a right to see it.”
Republicans on the committee have been largely silent.
The scientific community’s response has been louder. The American Medical Association issued a statement calling the suppression “deeply troubling” and urging the administration to restore the CDC’s independence in publishing peer-reviewed research. The Infectious Diseases Society of America echoed those concerns, warning that politicizing vaccine data could erode the public’s willingness to follow evidence-based health recommendations.
But the damage may already be done. Vaccine uptake for the updated COVID-19 shots has been sluggish. Only about 23% of U.S. adults received the 2024–2025 formulation, according to the most recent CDC data available before the agency’s public dashboards were scaled back earlier this year. Among adults 65 and older — the group most likely to die from COVID-19 — uptake was higher but still well below the levels public health officials consider adequate. Suppressing a study that demonstrates the vaccines’ benefits is unlikely to improve those numbers.
There’s a historical parallel worth considering. During the early years of the AIDS epidemic, political interference in public health messaging contributed to delays in prevention campaigns and research funding. The consequences were measured in deaths. Scientists and historians have spent decades documenting how the Reagan administration’s reluctance to engage with HIV/AIDS science prolonged the crisis. The current situation is different in scale and specifics, but the underlying dynamic — political considerations overriding scientific evidence — is uncomfortably familiar.
The blocked CDC study also fits into a broader global context. The World Health Organization has repeatedly warned that declining vaccine confidence in wealthy nations poses a major threat to pandemic preparedness. If the United States — home to the world’s largest biomedical research enterprise — is seen as suppressing its own vaccine data, the ripple effects could extend far beyond American borders. Countries that look to U.S. agencies for guidance on immunization policy may begin to question the reliability of American public health science altogether.
That’s not a hypothetical concern. It’s already happening. Public health officials in Europe and Asia have privately expressed alarm at the trajectory of U.S. health policy under the current administration, according to reporting from Reuters and The New York Times. Several countries have begun developing alternative data-sharing arrangements that bypass U.S. agencies entirely — a striking development for a nation that has long been the anchor of global health infrastructure.
Back in Atlanta, CDC scientists are demoralized. Morale at the agency was already low following rounds of layoffs and budget cuts. The blocked study has deepened the sense that career researchers are being sidelined in favor of political messaging. Some have begun quietly looking for positions in academia or the private sector. Others are staying but say they feel increasingly constrained in what they can study and publish.
“People are afraid,” said a current CDC researcher who asked not to be identified. “Not afraid of the virus. Afraid of their own government.”
The study itself remains in limbo. It has not been formally retracted or withdrawn — it simply hasn’t been allowed to see the light of day. The journal that accepted it has not commented publicly on the situation, though scientific publishing norms would typically prevent a journal from releasing a paper without the authors’ institution signing off. In this case, the institution is the federal government, and the federal government has said no.
Whether the study will eventually be released remains unclear. Legal experts say that Freedom of Information Act requests could potentially compel its disclosure, but such processes are slow and the administration has shown a willingness to fight FOIA demands in court. Congressional subpoena power is another avenue, but only if the majority party chooses to exercise it.
For now, the data sits locked behind a political decision. Americans heading into the next respiratory virus season will do so without access to a completed, peer-reviewed government study that could help them make informed choices about vaccination. The research exists. The evidence exists. The public just isn’t allowed to see it.
And in public health, what people don’t know can absolutely hurt them.
WebProNews is an iEntry Publication